Elisabeth Bjork
Independent DirectorDr. Elisabeth Björk, M.D., Ph.D., has been an Independent Director of Camurus AB (publ) since May 27, 2025 and serves as Director at Betula Consulting AB. She serves as Director at (earlier known as NodThera Limited) Rezera Inc. since June 2025. She is Director at Hansa Biopharma AB (publ) since September 02, 2025. Dr. Bjork serves as an Independent Director at Vicore Pharma Holding AB (publ) since May 11, 2023. She was Independent Director at Calliditas Therapeutics AB (publ) since May 19, 2022 until September 30, 2024. She had been Independent Director at Rocket Pharmaceuticals, Inc. since April 20, 2020 until May 20, 2026. Dr. Björk has been Non-Executive Director at Pharvaris N.V. since December 1, 2021. Dr. Björk has been Senior Vice President of Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM) - BioPharmaceuticals R&D at AstraZeneca PLC since 2020 and had been Senior Vice President of Late Cardiovascular, Renal & Metabolism of AstraZeneca PLC since 2020 until 2020 and served as its Senior Vice President since 2019 until 2020 and Head of Late-stage Development, Cardiovascular, Renal and Metabolism since July 2019 until 2020. She was Head of Late Cardiovascular, Renal and Metabolic (CVRM), BioPharmaceuticals R&D of AstraZeneca PLC since 2019 until July 2019. Dr. Björk served as Vice President of Late Clinical Development for AstraZeneca. Dr. Björk joined AstraZeneca in 2002. Dr. Björk served as a Director of Albireo AB. She is a scientific leader with rich experience in treating patients with chronic conditions. After training as an endocrinologist, she worked for several years in clinical practice and diabetes research at Uppsala University Hospital, in Sweden. She is also a board member of Chalmers University of Technology, Chalmers Ventures AB, Bj?rks Matematik o Mera AB and rfidcompare europe AB. She holds MD from Karolinska Institute and Ph.D. in Endocrinology from Uppsala University.
Positions
- Company NameVicore Pharma Holding AB (publ)Stock CodeVCREPositionIndependent DirectorColleagues
- ASAhmed S. MousaChief Executive Officer
- HJHans J. G. C. P. SchikanIndependent Chairman
- HJHans JeppssonChief Financial Officer
- MNMikael NygårdChief Operating Officer
- HBHelen BarkerChief Technology Officer
- RSRob SlackChief Scientific Officer
- HHHeidi HunterIndependent Director
- JGJacob GunterbergIndependent Director
- YBYasir B. Al-WakeelIndependent Director
